Skip to main content
Log in

Combined hormonal contraceptives: 2−4 weeks' cessation eliminates thrombotic risk

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Hugon-Rodin J, et al. Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives. Blood : 8 Nov 2023. Available from: URL: https://doi.org/10.1182/blood.2023021717

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Combined hormonal contraceptives: 2−4 weeks' cessation eliminates thrombotic risk. Reactions Weekly 1984, 7 (2023). https://doi.org/10.1007/s40278-023-50238-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-50238-y

Navigation